Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vinblastine”

77 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 77 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04576117
What this trial is testing

Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma

Who this might be right for
Recurrent Low Grade AstrocytomaRecurrent WHO Grade 2 GliomaRefractory Low Grade Astrocytoma+2 more
National Cancer Institute (NCI) 300
Testing effectiveness (Phase 2)Study completedNCT00412425
What this trial is testing

Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT02818725
What this trial is testing

I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations

Who this might be right for
Infiltrating Urothelial CarcinomaKRAS Gene Mutation
UNICANCER 133
Testing effectiveness (Phase 2)Ended earlyNCT03646123
What this trial is testing

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Seagen Inc. 255
Not applicableStudy completedNCT06857500
What this trial is testing

Brentuximab Vedotin with Adriamycin, Vinblastine and Dacarbazine for Patients Aged 18-59 Years with Untreated Advanced-stage Classical Hodgkin Lymphoma: a Real-life Experience

Who this might be right for
Classic Hodgkin LymphomaAdvanced Hodgkin Lymphoma
Federico II University 200
Testing effectiveness (Phase 2)Study completedNCT00030264
What this trial is testing

Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type 1Precancerous Condition
Children's Hospital of Philadelphia 23
Testing effectiveness (Phase 2)Study completedNCT01404936
What this trial is testing

Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Ended earlyNCT00722865
What this trial is testing

Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Massachusetts General Hospital 25
Post-approval studies (Phase 4)Looking for participantsNCT06831370
What this trial is testing

Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India

Who this might be right for
Hodgkin Lymphoma
Takeda 124
Large-scale testing (Phase 3)Study completedNCT00003376
What this trial is testing

Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Eastern Cooperative Oncology Group 330
Testing effectiveness (Phase 2)Active Not RecruitingNCT03033914
What this trial is testing

A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)

Who this might be right for
Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center 82
Testing effectiveness (Phase 2)Ended earlyNCT01542255
What this trial is testing

Metronomic Therapy in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Dartmouth-Hitchcock Medical Center 7
Large-scale testing (Phase 3)Study completedNCT01812369
What this trial is testing

Perioperative Chemotherapy for Patients With Locally Advanced Bladder Cancer

Who this might be right for
Bladder Cancer
University Hospital, Rouen 500
Testing effectiveness (Phase 2)Study completedNCT03058289
What this trial is testing

A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6

Who this might be right for
Breast CancerHead and Neck CancerSquamous Cell Carcinoma+8 more
Intensity Therapeutics, Inc. 111
Large-scale testing (Phase 3)Ended earlyNCT00005047
What this trial is testing

4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
SWOG Cancer Research Network 521
Not applicableStudy completedNCT07171827
What this trial is testing

Anti-CD30 (Brentuximab Vedotin) With AVD Versus ABVD Chemotherapy Protocol Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma

Who this might be right for
Anti-CD30BrentuximabDoxorubicin+4 more
Helwan University 60
Testing effectiveness (Phase 2)Study completedNCT00003084
What this trial is testing

Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 75
Testing effectiveness (Phase 2)Study completedNCT03331341
What this trial is testing

Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
University of Washington 50
Not applicableStudy completedNCT01868451
What this trial is testing

Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center 118
Large-scale testing (Phase 3)Looking for participantsNCT06960577
What this trial is testing

Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)

Who this might be right for
Urinary Bladder NeoplasmsImmune Checkpoint InhibitorsMethotrexate+4 more
AstraZeneca 150
Next Page